Diligence memo · auto-generated · as of July 2, 2026
Switch Bioworks, Inc.
Switch Bioworks, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Switch Bioworks, Inc. operates in Other Technology, based in SAN CARLOS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Switch Bioworks, Inc. has raised $23M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $23M on 2024-08-21.
Most recent recorded round closed around 2024-08-21.
Valuation (modeled)modeled
Provath models Switch Bioworks, Inc. at approximately $161M (range $55M–$280M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.75× the median modeled value of Series B Other Technology companies in 2022–2024 (514 peers) — value vs value, same stage and era. Within the normal band (75% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 22 mo ago; this sector typically re-raises about every 13 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 85% of Other Technology peers (21302 compared).
Modeled value ranks above 81% of those peers.
Closest niche peers: Contabilizei Co, Skan, Inc., Design Barn Inc., SKAEL, Inc., Maze.Design, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.